Skip to main content
Log in

Sind Protonenpumpenhemmer ein Risikofaktor für Clostridium-difficile-assoziierte Diarrhö?

Risk examined of proton pump inhibitors in diarrhea related to Clostridium difficile

  • Für Sie gelesen
  • Published:
Der Gastroenterologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Kyne L, Hamel MB, Polavaram R (2002) Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 34: 346–353

    Article  PubMed  Google Scholar 

  2. Parente F, Cucino C, Gallus S (2003) Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: A 1-month survey. Aliment Pharmacol Ther 17: 1503–1506

    Article  PubMed  CAS  Google Scholar 

  3. Yearsley KA, Gilby LJ, Ramadas AV (2006) Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea. Aliment Pharmacol Ther 24: 613–619

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H.P. Behrenbeck.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Behrenbeck, H. Sind Protonenpumpenhemmer ein Risikofaktor für Clostridium-difficile-assoziierte Diarrhö?. Gastroenterologe 3, 506–508 (2008). https://doi.org/10.1007/s11377-008-0248-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11377-008-0248-0

Navigation